Navigation Links
Index Ventures Closes Euro 350 Million Early Stage Fund

Ben Holmes Named Partner

LONDON, March 3 /PRNewswire/ -- Index Ventures today announced the closing of a euro 350 million early stage fund, Index Ventures V. The fund is dedicated to early stage and seed investments in the technology, biotechnology and clean technology sectors across Europe, the United States and Israel. It is the fifth early stage fund Index has raised in the past ten years and reinforces the firm's commitment to investing in innovative and disruptive companies, from the very earliest stages. The fund was raised almost entirely from the firm's existing base of limited partners.

"Over the past twelve years, we have been fortunate enough to work with some of the most successful entrepreneurs in the world who have started game-changing companies such as Betfair, Skype, MySQL and GenMab," said partner Bernard Dalle. "There are certainly challenges facing many industries right now but, thanks to the ongoing commitment of our limited partners, we can continue to focus on our core strength, that of finding and supporting ambitious, dedicated entrepreneurs."

Operating from offices in Geneva, London and Jersey, Index invests in companies across multiple geographies. Investments made during the last twelve months include: Criteo (France), DimDim (India), Lehigh Technologies (US), MyHeritage (Israel), NormOxys (France), OpTier (Israel), Playfish (UK), RightScale (US), and WooMe (UK/US).

Francesco De Rubertis, Index partner, added, "On the biotech side, Index is focused on finding the best companies with the strongest pipelines. We are equally interested in very early stage ventures and more mature companies with established proof-of-concept. In terms of therapeutic areas, our priorities are oncology, CNS, immunology and inflammation. We continue to see tremendous innovation and development within these areas, driven in part by the ever growing pharmaceutical pipeline deficit."

Index also announced today that Ben Holmes, a London-based member of the technology team since 2002, has been named a partner of the firm. Ben focuses on investments in consumer and internet infrastructure companies and currently sits on a number of boards including Mind Candy, Netlog, Playfish, Rebtel and Stardoll.

"Since joining our London office in 2002, Ben has played a key role in sourcing and supporting investments we have made in internet and software sectors," said Danny Rimer, partner at Index Ventures. "We are excited to announce his promotion and we look forward to his ongoing contributions to the firm and our portfolio companies."

In addition, Tony Zappala and Roman Fleck, both based in the firm's Geneva office, have been promoted to principals in the IT and biotech teams respectively.

About Index

Index Ventures is a leading venture capital firm active in venture investing since 1996. For more information, please visit

SOURCE Index Ventures
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Names New Senior Science Officer; Added to S&P Index
2. NASDAQ OMX AeA Illinois Tech Index Outperforms Market
3. Micromet Added to NASDAQ Biotechnology Index
4. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
5. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
6. Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
7. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
8. Advanced Life Sciences Added to Russell Microcap Index
9. Bioheart, Inc., Added to Russell Microcap Index
10. Pharmasset Joins Russell 3000 Index
11. Caliper Life Sciences Added to Russell 3000(R) Index
Post Your Comments:
(Date:10/12/2017)... ... 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK Business ... US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants module ... and biologic sealants used in surgical applications. BioMedGPS estimates the market will grow ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):